A total of six products were added in the month from six different asset managers: Franklin Templeton, Goldman Sachs, Impax, Jupiter, KPS Capital and Vanguard.
CCR Monthly Approval Report – September 2023
A total of five products were added in the month from four different brands: Franklin Templeton, Colchester, M&G, and Independencia.
CCR Monthly Approval Report – August 2023
JP Morgan, Dimensional, Franklin Templeton, DWS, Lazard, Morgan Stanley and AEA Investors were the fund sponsors gaining approval for new products in August.
CCR Monthly Approval Report – July 2023
A total of 27 products were added in the month from 10 different asset managers: American Century, Franklin Templeton, Comgest, Columbia Threadneedle, HSBC, Acadian, JPMorgan, Morgan Stanley, Invesco and KKR.
CCR Monthly Approval Report – June 2023
Mutual funds from Goldman, Man, Wellington and Moneda were approved in the month of June 2023.
CCR Monthly Approval Report – May 2023
BlackRock led with four ETFs of its iShares family, while EDM, JPMorgan, Patria and TJC completed the list each with one product approved.
CCR Monthly Approval Report – April 2023
American Century led with three ETFs registered in the month, while Robeco, with one mutual fund, completed the list.
CCR Monthly Approval Report – March 2023
A total of 17 products were added in the month from four different asset managers: WisdomTree, T. Rowe Price, Invesco, Capital Four, Equitix and Madison Realty Capital.
CCR Monthly Approval Report – February 2023
A total of five products were added in the month from five different asset managers: AllianceBernstein, Credicorp Capital, HIG Capital, Q-Energy and TA Associates.
CCR Monthly Approval Report – January 2023
Two ETFs, two mutual funds and one alternatives product gained CCR approval to kick off 2023. Sponsors gaining approval were Barings, GemCap, BNP Paribas, UBS and GlP.